Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern-Reference-Cited by-同舟云学术

Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern

Published:2021-10-18 Issue:11 Volume:7 Page:3034-3051
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Carter-Timofte Madalina Elena¹,Arulanandam Rozanne²,Kurmasheva Naziia¹,Fu Kathy³⁴⁵,Laroche Geneviève³⁴⁵,Taha Zaid²³,van der Horst Demi¹,Cassin Lena¹,van der Sluis Renée M.¹⁶,Palermo Enrico⁷,Di Carlo Daniele⁷,Jacobs David³⁴⁵,Maznyi Glib²,Azad Taha²³,Singaravelu Ragunath²,Ren Fanghui¹,Hansen Anne Louise¹,Idorn Manja¹,Holm Christian K.¹,Jakobsen Martin R.¹,van Grevenynghe Julien⁸,Hiscott John⁷,Paludan Søren R.¹,Bell John C.²³,Seguin Jean⁹,Sabourin Luc A.²¹⁰,Côté Marceline³⁴⁵^ORCID,Diallo Jean-Simon²³,Alain Tommy³¹¹,Olagnier David¹^ORCID

Affiliation:

1. Department of Biomedicine, Aarhus University, Aarhus C 8000, Denmark

2. Center for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, Ontario K1H 8L6, Canada

3. Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario K1H 8L1, Canada

4. Center for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, Ontario K1H 8L1, Canada

5. Ottawa Institute of Systems Biology, Ottawa, Ontario K1H 8L1, Canada

6. Aarhus Institute of Advanced Studies, Aarhus University, Aarhus 8000, Denmark

7. Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, Rome 00161, Italy

8. Institut National de la Recherche Scientifique (INRS)-Centre Armand-Frappier Santé Biotechnologie, Laval, Québec H7V 1B7, Canada

9. CCFP, Dipl. Sport Med., CareMedics McArthur, 311 McArthur Avenue suite 103, Ottawa, Ontario K1L 8M3, Canada

10. Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada

11. Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario K1H 8L1, Canada

Funder

Government of Canada

Region Midtjylland

Det Frie Forskningsr??d

Ontario Research Foundation

European Commission

Aarhus Universitets Forskningsfond

H??rslev-Fonden

CHEO Research Institute

Lundbeckfonden

Br????drene Hartman fond

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.1c00278

Reference36 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

3. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

4. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity;ChemMedChem;2024-08-06

2. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches;Cell Communication and Signaling;2024-02-15

3. Metabolic Profiling, Antiviral Activity and the Microbiome of Some Mauritian Soft Corals;Marine Drugs;2023-10-31

4. Tarsal exposure to atovaquone inhibits chikungunya virus transmission by Aedes aegypti mosquitoes, but not the transmission of Zika virus;Antiviral Research;2023-09

5. Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo;Viruses;2023-08-30